There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Next Science Ltd (NXSCF – Research Report), Mesoblast Limited (MEOBF – Research Report) and Pacific Edge Limited (PFGTF – Research Report) with bullish sentiments.
Next Science Ltd (NXSCF)
According to TipRanks.com, Jacobs is ranked #7446 out of 7941 analysts.
Currently, the analyst consensus on Next Science Ltd is a Moderate Buy with an average price target of $1.37.
See today’s best-performing stocks on TipRanks >>
Mesoblast Limited (MEOBF)
The company’s shares closed last Monday at $0.61, close to its 52-week low of $0.61.
According to TipRanks.com, Hester is a 1-star analyst with an average return of
Mesoblast Limited has an analyst consensus of Moderate Buy, with a price target consensus of $1.30.
Pacific Edge Limited (PFGTF)
The company’s shares closed last Monday at $1.20, equals to its 52-week high of $1.20.
Currently, the analyst consensus on Pacific Edge Limited is a Moderate Buy with an average price target of $0.68.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on NXSCF:
